Skip to content

Brain Oxygenation Monitoring in Patients Undergoing Coronary Artery Bypass Surgery

Prospective, Randomized Trial of Cerebral Oximetry Monitoring in Patients Undergoing Coronary Artery Bypass Surgery

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00137527
Enrollment
250
Registered
2005-08-30
Start date
2004-02-29
Completion date
2009-02-28
Last updated
2014-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological Manifestations

Keywords

Cardiac Surgery, Cardiopulmonary Bypass, Cerebral Oxygenation, Neurologic Dysfunction, Neurocognitive Dysfunction, Neurological manifestations, Memory loss, Delirium, Coronary Artery Bypass

Brief summary

The purpose of this study is to determine whether intraoperative brain oxygenation monitoring in cardiac surgery patients is effective in reducing postoperative neurologic and neurocognitive dysfunction.

Detailed description

This study represents a prospective, randomized assessment of the potential clinical and economic benefit to be derived from the continuous non-invasive monitoring of regional cerebral oxygen saturation (rSO2) during cardiac surgery employing cardiopulmonary bypass (CPB). Previous studies have shown that low rSO2 values obtained during surgery are highly associated with postoperative frontal lobe dysfunction, cognitive declines, disorientation, and other clinical indices of prolonged recovery. Low rSO2 values are thought to reflect the development of tissue hypoxia within susceptible regions of the cerebral cortex during the non-pulsatile perfusion of CPB. Rapid detection and correction of such episodes should help avoid regional hypoxia and its attendant postoperative sequelae. This study will assess neurologic, psychometric, and quality of life markers of brain dysfunction which could result from CPB. Each study patient will be assessed both pre- and postoperatively (pre-hospital discharge and at three months) for neurologic and neurocognitive dysfunction. Comparison(s): Intervention versus control group. Patients assigned to the intervention rSO2-monitored group will be managed with conservative measures designed to maintain the rSO2 value at, or above, its preoperative value. Such measures include increases in pump flow, blood pressure, anesthetic dose, arterial oxygen tension, carbon dioxide tension, and hematocrit. Those patients in the control group will be managed according to current established practice. Although rSO2 is also recorded in this group, the monitor's readings are blinded.

Interventions

DEVICEOptimizing hemodynamic and anesthetic parameters to improve cerebral perfusion

Sponsors

Atlantic Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Primary coronary artery bypass surgery * Ages 18-90 * Voluntary participation with signed informed consent

Exclusion criteria

* An unwillingness to participate in the study * Inability to obtain informed consent * Expressive or receptive aphasia * Inability to correctly perform the neurocognitive tests preoperatively * Inability to correctly perform the saccadic and anti-saccadic eye movement tests preoperatively * Non-English speaking candidates * Patients for whom it is known that follow-up will be improbable * Previous cardiac surgery * Concomitant procedures * Pre-existing psychotic disorders * Patients with active alcohol (ETOH) abuse requiring emergent surgery * Patients scoring 2 or higher on the CAGE evaluation * Mini-Mental State Exam preoperative score of 23 or less * Severe visual or auditory disorders * Parkinson's disease

Design outcomes

Primary

MeasureTime frame
Cognitive function measured by neurocognitive tests administered in the preoperative, immediate postoperative, and three months postoperative periods

Secondary

MeasureTime frame
Relationship of intraoperative risk data to postoperative cognitive function

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026